Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Daniel Skovronsky
since
auto-detected in 1 stories
6 months ago
Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.
page 1 of 1